COMMUNIQUÉ DE PRESSE publié le 01/01/2023 à 00:30, il y a 3 années 6 mois Ivrnet Inc. Announces Amendment to Term Loan and Credit Facility
COMMUNIQUÉ DE PRESSE publié le 31/10/2022 à 18:23, il y a 3 années 8 mois Paulic Meunerie : annule et remplace : Rapport financier semestriel 2022
COMMUNIQUÉ DE PRESSE publié le 24/11/2020 à 14:30, il y a 5 années 7 mois PJSC Magnit notifies on the transactions by persons discharging managerial responsibilities and persons clearly associated with them (PDMR/PCA)
COMMUNIQUÉ DE PRESSE publié le 24/11/2020 à 13:00, il y a 5 années 7 mois Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
Publié le 09/07/2026 à 07:30, il y a 5 heures 55 minutes Half-year liquidity contract statement June 30, 2026
Publié le 09/07/2026 à 07:30, il y a 5 heures 55 minutes Half-year liquidity contract statement June 30, 2026
Publié le 08/07/2026 à 20:00, il y a 17 heures 25 minutes ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 09/07/2026 à 13:00, il y a 25 minutes Evergold Mobilizes Drill to Golden Lion and Completes MobileMT Airborne Geophysical Survey, Toodoggone District, Northern BC
Publié le 09/07/2026 à 13:00, il y a 25 minutes Jaguar Mining Reports Commencement of Directional Drilling Program at Pilar Gold Mine, Minas Gerais, Brazil
Publié le 09/07/2026 à 13:00, il y a 25 minutes ATHA Energy Reports Widest Intersection to Date at Rib North Discovery with 37 m of Composite Uranium Mineralization in Ribn-DD-003 – Multiple Drillholes Demonstrating Continuity of Uranium Mineralization
Publié le 09/07/2026 à 12:30, il y a 55 minutes Relevant Gold Launches Fully Funded 2026 Drill Program and Receives Five-Year BLM Expanded Exploration Permit at Bradley Peak
Publié le 09/07/2026 à 12:35, il y a 50 minutes Cognizant to scale to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators
Publié le 09/07/2026 à 12:30, il y a 55 minutes Immunic to Participate in Investor Conferences in July
Publié le 09/07/2026 à 12:16, il y a 1 heure 9 minutes Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation